P1109: TRIAL IN PROGRESS: PHASE 1B/2 TRIAL OF TAZEMETOSTAT IN COMBINATION WITH VARIOUS TREATMENTS IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES

• A. Bessudo,
• D. Greenwald,
• M. H. Kazemi,
• A. Mahindra,
• L. Shunyakov,
• M. Sondhi,
• H. O’Connor,
• Y. Chen,
• J. Yang,
• G. Salles

Affiliations

A. Bessudo

1 cCare, Encinitas

D. Greenwald

2 UCLA, Santa Barbara

M. H. Kazemi

3 Astera Cancer Care, East Brunswick

A. Mahindra

4 Scripps MD Anderson Cancer Center, La Jolla

L. Shunyakov

5 Central Care Cancer Center, Bolivar

M. Sondhi

6 Epizyme, Inc., Cambridge

H. O’Connor

6 Epizyme, Inc., Cambridge

Y. Chen

6 Epizyme, Inc., Cambridge

J. Yang

6 Epizyme, Inc., Cambridge

G. Salles

7 Memorial Sloan Kettering Cancer Center, New York, United States of America